# Ele Ferrannini

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ele-ferrannini/

## Facts

| Field | Value |
| --- | --- |
| Citations | 84,938 |
| Field | Diabetes Treatment and Management |
| h-index | 129 |
| i10-index | 513 |
| Last Known Institution | Powertech Technology (Taiwan) |
| OpenAlex ID | https://openalex.org/A5089847244 |
| ORCID iD | https://orcid.org/0000-0002-1384-1584 |
| Works | 805 |

## Researcher papers

Showing 12 of 13.

- [Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy](https://scholariq.org/papers/medical-management-of-hyperglycemia-in-type-2-diabetes-a-consensus-algorithm-for/)
- [Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-a-patient-centered-approach/)
- [Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2015-a-patient-centered-approach/)
- [Type 2 diabetes mellitus](https://scholariq.org/papers/type-2-diabetes-mellitus/)
- [The Metabolic Syndrome: Time for a Critical Appraisal](https://scholariq.org/papers/the-metabolic-syndrome-time-for-a-critical-appraisal/)
- [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-executive/)
- [Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients](https://scholariq.org/papers/metabolic-response-to-sodium-glucose-cotransporter-2-inhibition-in-type-2/)
- [Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations](https://scholariq.org/papers/metabolic-surgery-in-the-treatment-algorithm-for-type-2-diabetes-a-joint/)
- [Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.](https://scholariq.org/papers/glucose-and-free-fatty-acid-metabolism-in-non-insulin-dependent-diabetes/)
- [How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial](https://scholariq.org/papers/how-does-empagliflozin-reduce-cardiovascular-mortality-insights-from-a-mediation/)
- [Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*](https://scholariq.org/papers/endothelial-function-and-dysfunction-part-ii-association-with-cardiovascular/)
- [Visceral Fat in Hypertension](https://scholariq.org/papers/visceral-fat-in-hypertension/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)

## Researcher university

- [Powertech Technology (Taiwan)](https://scholariq.org/institutions/powertech-technology-taiwan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.